News

New venture at Sciety – develops drugs for diseases caused by high levels of blood lipids

Lipid imbalances does not only cause common diseases such as diabetes and cardiovascular diseases but also various rare diseases. The pharma company Lipigon is specialised in diseases caused by lipid imbalances, with an initial focus on rare diseases that lack adequate treatments.     New candidate for treatment of severe disease The company’s main program…

Read more

Sciety raises new capital to MedTech company in neurology and cancer

CARTANA raised almost 10 MSEK in a share issue that was fully subscribed at the end of September. The company has developed reagents for analysing tissue samples in drug development processes and is based at Karolinska in Stockholm. The new capital will be used for sales of CARTANAS first product for brain research and for…

Read more

New venture at Sciety – wants to help researchers in the search for new treatments

Cartana is based at Karolinska Institutet in Stockholm and has developed a new technology for researchers to analyse tissue samples in drug development processes. The company is ready to launch at the market for brain research and will launch on the market for cancer research within a few years. As a result of more than…

Read more

Opportunity to join Cartana – their technology revolutionizes the brain research

Neurological disorders have been pinpointed by WHO as one of the greatest threats to public health. As an example, nearly 10 million people develop dementia each year and the number of people living with dementia is expected to triple from 50 million to 152 million by 2050. Today, the annual global cost for dementia is…

Read more

Sciety becomes a member in SwedenBIO

Sciety becomes a member in the trade association SwedenBIO that works for a strong life science sector in Sweden. The members include micro companies to big pharma but also companies that provide services in business development, IP, financing and etc. As Sciety works with financing of unlisted companies, in the life science sector exclusively, SwedenBIO…

Read more

Sciety raises 10 MSEK to diagnostics company fighting the tuberculosis epidemic

The new issue of shares in EMPE Diagnostics was fully subscribed already two weeks before the subscription period expired. EMPE Diagnostics develops a rapid test for diagnosis of tuberculosis. In total, 10 MSEK was invested and the funding will be used for final product validation and market launch. In the financing round, investors from the…

Read more
Mature surgeon consoling senior woman in examination room. Doctors and female patient are discussing CAT scan. They are in hospital.

An entrepreneurial and investor perspective on the action plan for Swedish life science

Last week, the trade associations LIF, Swedish Medtech and SwedenBIO presented an action plan to strengthen the competitiveness of Swedish life science. As Sciety meets many companies that develop the healthcare sector, we think that it is extra interesting that one of the three topics in the plan is to introduce innovative treatment methods. The…

Read more

Sciety raises 10 MSEK via its financing platform for companies in the life science sector

Sciety finalises a financing round of 10 MSEK and welcomes approximately thirty new shareholders with backgrounds in the finance and healthcare sectors. The largest investor is the investment company Linc. Sciety is an investment platform focusing on unlisted growth companies in the healthcare sector. Since Sciety’s launch during the autumn of 2016, Sciety has contributed…

Read more

Attana is the second company funded via Sciety to be listed on a stock exchange

One week ago, the medical technology company Attana that previously raised funding via Sciety listed its shares on the NGM stock exchange. The company has developed technology to improve efficiency in the development of new drugs. Attana is the second company that has been funded by Sciety to be listed on a stock exchange. Sciety…

Read more